Infectious Diseases (except HIV/AIDS)

  1. Efficacy and Safety of Leflunomide for Refractory COVID-19: A Pilot Study

    1. Qiang Wang
    2. Haipeng Guo
    3. Yu Li
    4. Xiangdong Jian
    5. Xinguo Hou
    6. Ning Zhong
    7. Jianchun Fei
    8. Dezhen Su
    9. Zhouyan Bian
    10. Yi Zhang
    11. Yingying Hu
    12. Yan Sun
    13. Xueyuan Yu
    14. Yuan Li
    15. Bei Jiang
    16. Yan Li
    17. Fengping Qin
    18. Yingying Wu
    19. Yanxia Gao
    20. Zhao Hu

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. Pooling for SARS-CoV-2 control in care institutions

    1. Jorge Julio Cabrera Alvargonzalez
    2. Sonia Rey Cao
    3. Sonia Pérez Castro
    4. Lucía Martinez Lamas
    5. Olaia Cores Calvo
    6. Julio Torres Piñon
    7. Jacobo Porteiro Fresco
    8. Julio Garcia Comesaña
    9. Benito Regueiro Garcia

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Quantitative assessment of the risk of airborne transmission of SARS-CoV-2 infection: Prospective and retrospective applications

    1. G. Buonanno
    2. L. Morawska
    3. L. Stabile

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. COVID-19: Why SOLIDARITY and DisCoVeRy trials may fail to bring informative and timely results

    1. Mondher Toumi
    2. Shuyao Liang
    3. Monique Dabbous
    4. Yitong Wang
    5. Tingting Qiu
    6. Ru Han

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Mathematical Modeling and Analysis of COVID-19 pandemic in Nigeria

    1. Enahoro Iboi
    2. Oluwaseun O. Sharomi
    3. Calistus Ngonghala
    4. Abba B. Gumel

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Antibody Profiling of COVID-19 Patients in an Urban Low-Incidence Region in Northern Germany

    1. Werner Solbach
    2. Julia Schiffner
    3. Insa Backhaus
    4. David Burger
    5. Ralf Staiger
    6. Bettina Tiemer
    7. Andreas Bobrowski
    8. Timothy Hutchings
    9. Alexander Mischnik

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. CIGB-258 immunomodulatory peptide: a novel promising treatment for critical and severe COVID-19 patients

    1. R Venegas-Rodriguez
    2. R Santana-Sanchez
    3. R Peña-Ruiz
    4. M Bequet-Romero
    5. M Hernandez-Cedeño
    6. B Santiesteban-Licea
    7. A Garcia
    8. PR Aroche
    9. D Oliva-Perez
    10. LM Ortega-Gonzalez
    11. J E Baldomero
    12. LR Cruz
    13. G Guillén
    14. G Martinez-Donato
    15. MC Dominguez-Horta
    16. for the CIGB-258 Study Group

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. The prevalence of antibodies to SARS-CoV-2 in asymptomatic healthcare workers with intensive exposure to COVID-19

    1. Shue Xiong
    2. Chunxia Guo
    3. Ulf Dittmer
    4. Xin Zheng
    5. Baoju Wang

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Individuals with Down syndrome hospitalized with COVID-19 have more severe disease

    1. Louise Malle
    2. Cynthia Gao
    3. Chin Hur
    4. Han Q. Truong
    5. Nicole M. Bouvier
    6. Bethany Percha
    7. Xiao-Fei Kong
    8. Dusan Bogunovic

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Correlation of the global spread of coronavirus disease-19 with atmospheric air temperature

    1. Yihienew M. Bezabih
    2. Alemitu Mequanint
    3. Endalkachew Alamneh
    4. Alemayehu Bezabih
    5. Wilber Sabiiti
    6. Anna Roujeinikova
    7. Woldesellassie M. Bezabhe

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 55 of 716 Next